Kevin Eggan, Ph.D., joined BioMarin in October 2020 and serves as Group Vice President, Head of Research and Early Development. He is responsible for the execution of BioMarin’s discovery research programs, helping to shape the vision and long-term growth of our company through the oversight of an exceptional research pipeline of first- or best-in-class therapies.
Learn more about Kevin here: https://www.biomarin.com/our-science/our-scientists/kevin-eggan-phd/
Source BioMarin Pharmaceutical YouTube
